Nawal Boukli

Associate Professor
Proteomics Facility Director
Ph.D. 2000, University of Geneva

Academic Department(s)
Microbiology and Immunology

Research Area
Cancer Biomarkers
HIV and Substance Abuse

Research Interest
HIV type B is more neurotoxic than type C affecting the human brain differently.  We are investigating molecular mechanism in human neurons that could explain this difference.

Anti-tumor activity of natural compounds in prostate, colon and pancreas cancer cell lines.
 

Dr. Boukli’s goal is to identify biomarkers associated with neurocognitive impairment, HIV and drug abuse. The risk of neurocognitive decline in HIV infection together with the lack of biomarkers useful in early treatment has fostered recent attempts at defining risk factors and identifying new biomarkers associated with HIV-associated neurocognitive disorders (HAND). Psychoactive substance abuse appears to account for increased neurocognitive impairment (NCI) in the context of HIV infection. The results from this research will help to determine the association of drug abuse, HIV and their combination on expression of neurocognitive impairment biomarkers.  Students will be involved in the identification of cellular stress, apoptosis, and neurocognitive impairment biomarkers in peripheral blood mononuclear cells.


Publications
 
http://www.ncbi.nlm.nih.gov/sites/myncbi/1FA5Ag6nojNAx/collections/46337441/public/
 
Contact Information
Universidad Central del Caribe
P.O. Box 60327
Bayamón, PR 00960-6032

Tel (787) 798-3001  ext. 2080
e-mail: nawal.boukli@uccaribe.edu